
Nociceptin/orphanin FQ opioid peptide (NOP) receptor and µ-opioid peptide (MOP) receptors both contribute to the anti-hypersensitive effect of cebranopadol in a rat model of arthritic pain
Keywords: Cebranopadol (PubChem CID: 11848225); J-113397 (PubChem CID: 5311194); morphine (PubChem CID: 5288826); naloxone (PubChem CID: 5284596); Ro65-6570 (PubChem CID: 5512229); Cebranopadol; Morphine; Nociceptin/orphanin FQ opioid peptide receptor; Opioid pepti